Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-04-01
1993-04-13
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546333, A61K 31435, A01N 4340
Patent
active
052023311
ABSTRACT:
A method for the therapeutic treatment of dysuria with alpha-phenyl-alpha-pyridylakanoic acid derivatives is disclosed.
REFERENCES:
patent: 4564621 (1986-01-01), Ueda et al.
patent: 4766213 (1988-08-01), Juraszyk et al.
patent: 4857535 (1989-08-01), Davis
patent: 4957941 (1990-09-01), Davis
The American Journal of Surgery, vol. 145, No. 5, May 1983, pp. 558-561; J. D. Giesy et al.: "Micturition Neuropharmacology".
Clinics in Ohstetrics and Gynaecology, vol. 8, No. 1, Apr. 1981, pp. 149-160, W. B. Saunders Co., Ltd.; F. B. Gibberd: "The Neurogenic Bladder".
Arch. Intern. Med., vol. 143, Sep. 1983, pp. 1683-1686; L. H. Danziger et al.: "Disopyramide-Induced Urinary Retention".
The Merck Manual, 15th edition, 1987, p. 1553, edited by R. Berkow et al, Merck & Co., Inc., Rahway, N.J. US.
Medicinal Chemistry 3rd ed., Wiley-Interscience New York, N.Y. p. 76 (1970).
Oyo Yakuri/Pharmacometrics 39(6):595-599, 1990.
Merck Index 10th ed., Merck & Co., Rahway, N.J. 1983, p. 68.
Fujisawa Pharmaceutical Co. Ltd.
Tsung Fred
Waddell Frederick E.
LandOfFree
Therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyri does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyri will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1155571